Fred Parks, PhD
Chief Executive Officer
Fred Parks has served as a Director of Nuvectra since March 2016 and was named CEO of Nuvectra in February 2019. He was most recently the President and Chief Executive Officer of Analogic Corporation, a medical imaging and aviation security company, from October 2016 to June 2018. Mr. Parks was also the Chief Executive Officer of Enovate Medical from July 2015 until October 2016. Prior to joining Enovate Medical, Mr. Parks served as Chief Executive Officer of NDS Surgical Imaging, LLC, from August 2011 to 2013 and as Chairman and Chief Executive Officer of Urologix, Inc., from May 2003 to February 2008. Prior to joining Urologix, Mr. Parks served as President and Chief Executive Officer of Marconi Medical Systems, which is currently part of Philips Medical Systems. Through his career he has served as a director of Analogic Corporation, Enovate Medical, NDS Surgical Imaging, Urologix, EG&G, Inc. (now PerkinElmer), St. Jude Medical, and Steady State Imaging. Mr. Parks received a B.S. in Mechanical Engineering from University of Missouri-Rolla, an M.S. in Mechanical Engineering from the University of Arizona, and a Ph.D. in Mechanical Engineering from the University of Missouri-Columbia.
Executive Vice President, General Counsel
Melissa Beare joined the Nuvectra organization in 2015 as Vice President, General Counsel and Chief Compliance Officer responsible for all of the company’s legal matters and its compliance program. Ms. Beare has more than 5 years of experience in the medical device industry. Prior to joining Nuvectra, Ms. Beare was Assistant General Counsel at Speed Commerce, Inc. She also spent 5 years as the General Counsel at Peerless Mfg. Co. in Dallas, Texas and over 4 years as Assistant General Counsel at St. Jude Medical’s Neuromodulation Division. She began her career in the corporate practice groups at the firms of Hughes & Luce and Jones Day. Ms. Beare has a B.A. and a J.D. from the University of Texas at Austin.
Executive Director, Regulatory & Clinical Affairs
Bernie Bosley joined the Nuvectra organization in 2017 as Executive Director for Regulatory and Clinical Affairs responsible for the company’s regulatory compliance and clinical studies. Mr. Bosley has more than 23 years of experience in the active implantable medical device industry. Prior to joining Nuvectra, Mr. Bosley worked at Medtronic in several divisions including Brady Pacing, Gastroenterology/Urology, Electrophysiology, and Neuromodulation. Mr. Bosley was also an independent consultant in the medical device industry for 7 years which included consulting for the startup company (QiG) that formed into the Nuvectra Corporation. Mr. Bosley is a licensed professional engineer and holds a B.S. in Mechanical Engineering from the University of Minnesota Institute of Technology.
Prior to joining Nuvectra as President, Paul Hanchin served as Executive Vice President for Flowonix Medical, Inc., where he had primary responsibilities for global sales and marketing functions. Before that, he served as the President for Ethos Laboratories. Mr. Hanchin has 30 years of experience in the medical device field, including executive leadership positions at small and large, high-growth companies. He served as Division Vice President for St. Jude Medical from 2005 to 2013, with general management responsibilities for the Neuromodulation and Structural Heart divisions. He has also served in a wide variety of general management, sales, and marketing positions at Boston Scientific, Inc., Cyberonics Inc. and Advanced Neuromodulation Systems, Inc., which was acquired by St. Jude Medical, Inc. Mr. Hanchin has a B.A. in Marketing from Baldwin Wallace University and is a graduate of Kellogg School of Management’s Executive Program.
Vice President, Chief Information Officer
Prior to joining Nuvectra in December of 2015, Mr. Harvey held various senior level information technology roles. He was the CIO at Ultra Mobile, a start-up pre-paid wireless company, where he built an IT organization to deliver core enterprise platforms and product-related technology. Mr. Harvey was CTO for MUVE Music, a division of Leap Wireless International, Inc. (NASDAQ), where he delivered an industry-leading mobile music platform for Cricket Wireless. Mr. Harvey was also CIO and Vice President for Cricket Communications, Inc., (Leap Wireless); CIO for Boost Mobile, a division of Sprint/Nextel and Vice President of Delivery; and Supplier Management at Sprint/Nextel. He brings decades of experience in software engineering and delivery, IT architecture, technology strategy and end-to-end delivery of technology solutions that solve critical business needs. Mr. Harvey attended Syracuse University.
Interim Chief Financial Officer, Vice President, Controller and Principal Accounting Officer
Jennifer Kosharek joined Nuvectra in January 2016 as Executive Director, Corporate Controller, and was appointed Vice President, Controller and Principal Accounting Officer, in June 2018. Ms. Kosharek leads the company’s external financial reporting, corporate accounting, corporate internal controls, shared services, payroll, and tax functions. Ms. Kosharek has held various finance and leadership positions and has more than 15 years of audit and accounting experience, including 7 years of public company accounting experience. Prior to joining Nuvectra, Ms. Kosharek was the Corporate Controller and subsequently served as the Chief Financial Officer and Vice President of Finance of Interphase Corporation from 2011 to 2015. Preceding her position at Interphase, Ms. Kosharek served as Senior Accountant – External Reporting and later as Accounting Manager at Sabre Holdings from 2008 to 2011. She began her career at Grant Thornton, LLP. Ms. Kosharek is a Certified Public Accountant and holds a Master’s of Public Accountancy from the University of Wisconsin-Whitewater.
Vice President, Business Development
Alan Mock joined the Nuvectra organization as part of QiG Group in April 2013 as Vice President of Commercialization and is responsible for developing and executing the commercialization plan for Nuvectra. Mr. Mock has more than 30 years of medical device experience in all aspects of sales and marketing. Prior to Nuvectra, Alan spent 15 years with Advanced Neuromodulation Systems (ANS) and, later, St. Jude Medical (SJM) as VP of Marketing for Chronic Pain Therapies and later as VP of Sales and Marketing for Neuro Therapies. During this time at ANS/SJM, he was responsible for the global commercialization of multiple product lines. Prior to ANS, Mr. Mock was VP of Sales and Marketing for Snowden-Pencer. Mr. Mock has a B.A. from the University of Florida.
Vice President, Chief Human Resources Officer
Bonnie Schmidt joined Nuvectra in 2015 as Director of Human Resources and is responsible for strategic and functional responsibilities across all HR disciplines. Ms. Schmidt has more than 20 years of human resources experience across numerous industries including medical devices, pharmaceutical commercialization, and healthcare analytics. Prior to joining Nuvectra, she served as the Director of HR for Sonexus Health, a Cardinal Health company. Preceding her position at Sonexus Health, Ms. Schmidt served as Senior HR Manager for St. Jude Medical. Ms. Schmidt has an M.B.A. in Healthcare Management from the University of Scranton and a B.A. from the University of Phoenix-Dallas.
Chief Technology Officer
Ben Tranchina joined Nuvectra in August of 2018. He has more than 25 years of experience in technology business leadership in both early-stage and multi-national commercial companies and holds approximately 30 issued or pending patents relevant to neuromodulation. Prior to joining Nuvectra as Chief Technology Officer, Mr. Tranchina served as the Chief Technology Officer for Neurotechnology Innovations Translator (NIT) LLC, a privately held company in Columbus, Ohio, which develops and commercializes neurotechnology solutions. During his tenure at NIT, Mr. Tranchina also served as CEO for NIT portfolio company Veressa Medical where he led the development of an innovative peripheral nerve stimulation system for the treatment of pelvic floor dysfunction and peripheral pain. Before that, Mr. Tranchina served in various leadership roles and as VP of Research and Development for ten years at St. Jude Medical’s (SJM) Neuromodulation Division and Advanced Neuromodulation Systems, Inc. (ANSI), a company acquired by St. Jude Medical, Inc., in 2005. During his time at SJM, Mr. Tranchina’s teams launched nine first-to-market products, and, as a result, he was awarded SJM’s Neuromodulation Inventor of the Year award. Mr. Tranchina holds a B.S. and a M.S. in Electrical Engineering from the University of Texas at Dallas, specializing in Microelectronic Circuits and Systems.